Detalles de la búsqueda
1.
Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer.
N Engl J Med
; 380(7): 617-628, 2019 02 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-30516102
2.
What does Medicaid expansion mean for cancer screening and prevention? Results from a randomized trial on the impacts of acquiring Medicaid coverage.
Cancer
; 122(5): 791-7, 2016 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26650571
3.
A Randomized Trial of Fulvestrant, Everolimus, and Anastrozole for the Front-line Treatment of Patients with Advanced Hormone Receptor-positive Breast Cancer, SWOG S1222.
Clin Cancer Res
; 28(4): 611-617, 2022 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34844978
4.
Changes in T-cell subsets and clonal repertoire during chemoimmunotherapy with pembrolizumab and paclitaxel or capecitabine for metastatic triple-negative breast cancer.
J Immunother Cancer
; 10(1)2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35086949
5.
A Phase Ib Study of Preoperative, Locoregional IRX-2 Cytokine Immunotherapy to Prime Immune Responses in Patients with Early-Stage Breast Cancer.
Clin Cancer Res
; 26(7): 1595-1605, 2020 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31831558
6.
Beyond cytotoxic chemotherapy for the first-line treatment of HER2-negative, hormone-insensitive metastatic breast cancer: current status and future opportunities.
Clin Breast Cancer
; 8(3): 215-23, 2008 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-18650151
7.
Cognitive Complaints in Survivors of Breast Cancer After Chemotherapy Compared With Age-Matched Controls: An Analysis From a Nationwide, Multicenter, Prospective Longitudinal Study.
J Clin Oncol
; 35(5): 506-514, 2017 Feb 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28029304
8.
Epirubicin With Cyclophosphamide Followed by Docetaxel With Trastuzumab and Bevacizumab as Neoadjuvant Therapy for HER2-Positive Locally Advanced Breast Cancer or as Adjuvant Therapy for HER2-Positive Pathologic Stage III Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group, FB-5.
Clin Breast Cancer
; 17(1): 48-54.e3, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27693116
9.
Dermatological toxicity of ixabepilone.
Anticancer Res
; 26(3B): 2279-80, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-16821602
10.
Randomized phase II trial of weekly vs. every 2 weeks vs. every 3 weeks nanoparticle albumin-bound paclitaxel with bevacizumab as first-line chemotherapy for metastatic breast cancer.
Clin Breast Cancer
; 13(4): 239-246.e1, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23829890
11.
Phase II trial of weekly nanoparticle albumin-bound paclitaxel with carboplatin and trastuzumab as first-line therapy for women with HER2-overexpressing metastatic breast cancer.
Clin Breast Cancer
; 10(4): 281-7, 2010 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20705560
12.
Taxanes in breast cancer: an update.
Curr Oncol Rep
; 9(1): 22-30, 2007 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-17164044
13.
Use of the Oncotype DX 21-gene assay to guide adjuvant decision making in early-stage breast cancer.
Mol Diagn Ther
; 11(6): 355-60, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-18078353
14.
Point: combination versus single-agent chemotherapy: the argument for sequential single agents.
J Natl Compr Canc Netw
; 5(8): 668-72, 2007 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-17927924
Resultados
1 -
14
de 14
1
Próxima >
>>